Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Ethos Technologies Inc. - Class A Common Stock (NQ:LIFE)

22.97 +2.55 (+12.49%)
Streaming Delayed Price Updated: 2:04 PM EDT, Aug 3, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Ethos Technologies Inc. - Class A Common Stock

< Previous 1 2 3 4 5 Next >
News headline image
Ethos and North American Expand Their Indexed Universal Life Product Offering to include Children
Ethos' digital application and underwriting platform makes it faster and easier than ever for parents to build tax-advantaged financial security with death benefit protection for their children 
From Ethos Technologies Inc
Via GlobeNewswire
News headline image
Ethos Partners with Amanda Kloots to Help Families Take Control of the One Thing They Can
Drawing on her public experience of losing her husband during COVID, Kloots brings an urgent and deeply personal voice to Ethos' mission of making life insurance accessible for every family 
From Ethos Technologies Inc
Via GlobeNewswire
News headline image
Ethos to Announce Second Quarter 2026 Financial Results on August 3, 2026
From Ethos Technologies Inc
Via GlobeNewswire
ETHOS TECHNOLOGIES INC CL-A (NASDAQ:LIFE) Revenue Beat and Profitability Surprise Masked by GAAP Loss and Stock Compensation ↗
Via Chartmill
News headline image
Ethos Technologies Shares Tumble As Bear Cave Takes Aim ↗
Shares of Ethos Technologies Inc (NASDAQ: LIFE) are trading sharply lower on Thursday after short-selling newsletter The Bear Cave published a highly critical report on the digital life insurance... 
Via Benzinga
News headline image
Ethos Partners with Baseball Legend David Ortiz to Champion Life Insurance as a Family Financial Essential
New campaign draws on Ortiz’s deeply personal losses—and his own near-death experience—to inspire families to protect what matters most 
From Ethos Technologies Inc
Via GlobeNewswire
News headline image
Ethos to Present at Upcoming Investor Conferences
From Ethos Technologies Inc
Via GlobeNewswire
News headline image
Ethos Announces Early Lock-Up Release
From Ethos
Via Business Wire
News headline image
Ethos Announces Early Lock-Up Release
From Ethos Technologies Inc
Via GlobeNewswire
News headline image
Ethos (LIFE) Q1 2026 Earnings Call Transcript ↗
Ethos (LIFE) Q1 2026 Earnings Call Transcript 
Via The Motley Fool
Topics Earnings Initial Public Offering
News headline image
Ethos Reports First Quarter Fiscal Year 2026 Financial Results
From Ethos Technologies Inc
Via GlobeNewswire
News headline image
Ethos Launches ChatGPT App To Bring Instant Life Insurance Estimates to 900 Million Users
First life insurance app on ChatGPT enables personalized term estimates in under a minute — no medical exam, no phone calls, no friction 
From Ethos Technologies Inc
Via GlobeNewswire
News headline image
Ethos Collaborates with Liberty Mutual to Deliver a Modern, Digital-First Life Insurance Experience
Liberty Mutual to enhance purchase experience leveraging Ethos’ technology platform 
From Ethos Technologies Inc
Via GlobeNewswire
News headline image
Ethos to Announce First Quarter 2026 Financial Results on May 6, 2026
From Ethos Technologies Inc
Via GlobeNewswire
News headline image
Ethos and Banner Life Expand Offering to Bring Final Expense Coverage to More Families
From Ethos Technologies Inc
Via GlobeNewswire
News headline image
Ethos to Participate in The Citizens Technology Conference
From Ethos Technologies Inc
Via GlobeNewswire
News headline image
Ethos and North American Collaborate to Offer Accumulation Indexed Universal Life Product
From Ethos Technologies Inc
Via GlobeNewswire
News headline image
Ethos and Aflac Partner to Bring Supplemental Health Product Suite to Independent Distribution
From Ethos Technologies Inc
Via GlobeNewswire
News headline image
Ethos Files Registration Statement for Proposed Initial Public Offering
From Ethos Technologies Inc
Via GlobeNewswire
News headline image
2 Small-Cap Biotech Stocks Well Positioned for a Breakout ↗
Clinical trial results expected in the weeks ahead could push shares of these small-cap drugmakers through the roof. 
Via The Motley Fool
News headline image
Ethos and Lifeforce Team Up to Help Policyholders Live Longer, Healthier Lives
New benefit gives Ethos policyholders access to Lifeforce’s comprehensive health optimization platform, including biomarker testing, evidence-based longevity protocols, and expert health coaching 
From Ethos Technologies Inc
Via GlobeNewswire
News headline image
3 Innovation Stocks With Parabolic Upside Potential ↗
These three growth stocks might be deeply undervalued. 
Via The Motley Fool
Topics Artificial Intelligence
News headline image
1 Small-Cap Biotech Stock Poised for a Breakout ↗
This developmental biotech is nearing a key inflection point. 
Via The Motley Fool
Topics Economy
News headline image
Insurtech Leader Ethos Adds Industry Veteran William Wheeler to Board of Directors
Former President of Athene brings decades of insurance, retirement, and financial services leadership to support Ethos’ next stage of growth 
From Ethos Technologies Inc
Via GlobeNewswire
News headline image
Millionaire Makers: 7 Stocks You Can Buy for $2 That Can 10X by 2025 ↗
These 10X penny stocks have the potential to mint millionaires with enough capital but buy wisely as the risk is real. 
Via InvestorPlace
News headline image
aTyr Pharma Announces Nasdaq Stock Ticker Symbol Change from “LIFE” to “ATYR”
Ticker symbol change to take effect on Wednesday, June 5, 2024 
From aTyr Pharma, Inc.
Via GlobeNewswire
News headline image
aTyr Pharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From aTyr Pharma, Inc.
Via GlobeNewswire
News headline image
aTyr Pharma to Present Poster Describing Efzofitimod’s Mechanism of Action at the American Thoracic Society 2024 International Conference
Findings further demonstrate that NRP2 is an important new immune target in ILD and that efzofitimod modulates myeloid cells to confer anti-inflammatory benefit 
From aTyr Pharma, Inc.
Via GlobeNewswire
News headline image
aTyr Pharma Announces Second Positive DSMB Review for Efzofitimod in Phase 3 EFZO-FIT™ Study in Pulmonary Sarcoidosis
From aTyr Pharma, Inc.
Via GlobeNewswire
News headline image
aTyr Pharma to Present at Upcoming Investor Conferences
From aTyr Pharma, Inc.
Via GlobeNewswire
< Previous 1 2 3 4 5 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.